Numerous clinical trials have studied the role of bone antiresorptive therapy for prevention of bone density loss and fractures.
已经有很多临床试验研究了骨的抗再吸收治疗在预防骨密度丢失和骨折中的作用。
Zoledronic acid previously has been shown to prevent bone mineral density loss in prostate cancer patients just beginning hormone therapy.
患者开始进行激素治疗时使用唑来瞵酸能够保护骨密度降低的疗效,已被证实。
In a study of more than 200 women ages 46 to 65, researchers found that the soy supplement did not appear to ward off bone-density loss over 3 years.
在一项对200多名年龄在46到65岁的女性调查研究中,研究者发现,在这3年当中大豆补充品并没有防止骨密度的减少。
应用推荐